Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
MELVILLE, N.Y., Sep 17, 2009 (BUSINESS WIRE) -- OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue...
DEERFIELD, IL, September 15, 2009 – Astellas Pharma US, Inc. today announced the winners of the Astellas Ride of a LifetimeSM 2010 contest. The contest asked transplant recipients to submit...
Chicago Mayor Richard M. Daley honored Astellas Pharma US, Inc. and two other Chicagoland companies on Aug. 14 at a ceremony in downtown Chicago with an award for their exemplary learning and...
Read more about Chicago Mayor Honors Astellas' Excellence in Learning, Development
Astellas Pharma US, Inc. ("Astellas") announced today an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's...
In a ceremony recognizing "Chicago's 101 Best and Brightest Companies to Work For," Astellas Pharma US, Inc. won an Elite award for employee engagement and commitment by the National Association...
Follow U.S. news
